Agoracom Blog Home

Posts Tagged ‘CSE’

Precious Metal Growth Potential In 2020 – SPONSOR: New Age Metals $NAM.ca $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN #Palladium #Platinum #PGM

Posted by AGORACOM-JC at 6:11 PM on Tuesday, March 31st, 2020

SPONSOR: New Age Metals Inc. The company owns one of North America’s largest primary platinum group metals deposit in Sudbury, Canada. Updated NI 43-101 Mineral Resource Estimate 2,867,000 PdEq Measured and Indicated Ounces, with an additional 1,059,000 PdEq Ounces Inferred. Learn More.

Precious Metal Growth Potential In 2020

By: Tyler Gallagher

Precious metals investors had an excellent 2019, with gold, silver, platinum and palladium seeing sustained growth over a 12-month period. Gold eclipsed the critical resistance barrier of $1,500 per ounce in September. Other metals saw even more impressive growth, but none more than palladium, the most valuable of the four major precious metals. Palladium, a lustrous platinum-group metal, saw a price increase of 59% on the year. Silver experienced a more modest gain of 15.3% over the same period, and platinum boasted a 21.6% year-end gain.

Overall, the 2019 precious metals market was a dream come true for investors.

As CEO of an international alternative assets firm, I’ve helped countless investors diversify their investment portfolios and 401(k)/IRA retirement accounts with precious metals. With the knowledge gathered from over a decade of experience, I’ve put together a list of metals with the best upside potential in the year ahead.

Silver: Modest Upside, Moderate Risk

Silver is perhaps the most unique precious metal. China is by far the world’s largest silver consumer due to its massive industrial economy and manufacturing sector, which utilizes silver in the production of solar panels, electric vehicle parts and more.

However, production slowdowns due to the spread of the novel coronavirus could limit industrial output and cause a decline in global silver demand. Ultimately, I predict that silver will remain a strategic metal with industrial applications that will likely see moderate price increases in 2020. The extent to which it increases will be dependent on the current pandemic and whether Chinese and U.S. leaders successfully negotiate a phase-two trade deal.

Gold: A Blue-Chip Holding

There’s little doubt that gold will perform reasonably well in 2020. I observed gold entering a bull market in 2019 due to increased geopolitical risk, U.S. economic uncertainty, low U.S. bond yields and a repo market scare. Today, many of those growth conditions remain in place.

The yellow metal thrives during times of global economic crises. Since the United Kingdom formally left the European Union (EU) on January 31, and U.S. President Trump’s trade agenda with China remains unclear, there is a high degree of uncertainty in the global economy. If the EU continues to unravel or if another constituent member signals its intention to leave, I expect gold prices to surge. Likewise, if the implementation of the phase-one U.S.-China trade deal is rolled back, we will likely see an uptick in the price of gold.

Other circumstances, such as a rapidly expanding repo market and the potential for further cuts to the federal funds rate, point to strong growth for gold in the year ahead. Debt loads are increasing among both corporations and governments, which also indicate growth potential for gold.

Platinum: A Riskier Investment

Platinum is coming out of an over seven-year bear market that saw its price stagnate amid consistent growth across all other precious metals. Despite being rarer than gold, platinum is used in a range of industrial applications, including in the production of satellite technologies and fuel cells in electric vehicles, as well as in healthcare instruments such as pacemakers.

Three-quarters of the world’s platinum supply is mined in South Africa. However, many of the leading mines in the country have been mired in controversy following human rights scandals and disruption by labor union action. How these controversies and disruptions will play out in 2020 will have an effect on the price of the precious metal.

At best, I expect platinum to see low to moderate growth in 2020. It’s more likely, however, that platinum prices will stagnate given low investment in South African mines.

Investing In Precious Metals In 2020

Overall, I conclude that the precious metals market in 2020 is looking up. The same forces responsible for last year’s jaw-dropping growth remain in place today, and analysts have no reason to suspect these conditions to change in the months ahead. Trade tensions, geopolitical escalation and equity market volatility point toward another year of growth.

This means it’s a good time for entrepreneurs to invest in gold and other high-growth precious metals. During times of great volatility and economic crisis, precious metals can add much-needed diversification to your portfolio so you can safeguard more of your wealth and weather the storm when traditional asset markets suffer and sales decline.

Gold will likely be the safest pick, followed by palladium, with silver a sleeper pick at third. I predict that gold will remain a safe haven store of value during economic and political uncertainty, which makes it a blue-chip investment in 2020 for those looking to achieve diversification and insulate their portfolio against stock and bond market volatility. However, more risk-tolerant investors may consider allocating a minority share of their precious metal allocation to palladium and silver as well.

Source: https://www.forbes.com/sites/theyec/2020/03/30/precious-metal-growth-potential-in-2020/#36c33d0b16c8

Datametrex $DM.ca Working With US Government Agencies on #Covid19 and #Coronavirus Fake News and Disinformation

Posted by AGORACOM-JC at 1:52 PM on Monday, March 30th, 2020
  • Currently working with various agencies within the United States Government on the mass amount of social media surrounding #coronavirus and #covid19
  • First contract with clients is a pilot for $25,000 USD
  • It was signed on March 12th, 2020 and has a duration of one month

TORONTO, March 30, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) is pleased to share that Company is currently working with various agencies within the United States Government on the mass amount of social media surrounding #coronavirus and #covid19. We will provide greater detail on the work we are doing once it is completed and our clients approve it for public dissemination. 

The Company wishes to provide further details to this release as requested by IIROC. This first contract with our clients is a pilot for $25,000 USD. It was signed on March 12th, 2020 and has a duration of one month. The clients contacted Datametrex after witnessing the technology at a NATO working group presentation highlighting Nexalogy’s work on #fakenews and #disinformation in the Canadian Federal Elections. This Pilot represents a major milestone for the Company as it is the natural progression to potentially expand into the US market, specifically the US Government.  

“We are thrilled to be working with the US Government on this very important issue. We recently completed work for Democracy Labs on #disinformation in social media regarding #covid19 and #Coronavirus and secured a relationship with Carnegie Mellon University IDeaS. Both announcements assisted in getting Nexalogy in front of the Government Agencies for this current opportunity in the United States. The solid foundation we have built over the past years with our Canadian Government clients like  DRDC, the Canadian Military and NATO have positioned Datametrex to be able to provide military grade solutions for todays social media challenges”, says Marshall Gunter CEO of Datametrex AI.

About Datametrex AI Limited

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at: www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Work on PUREVAP #Silicon Metal Nano Reactor Continues as $HPQ.ca Provides Update on COVID-19 Outbreak Impact $FSLR $SPWR $CSIQ $PYR.ca $XMG.ca

Posted by AGORACOM-JC at 11:01 AM on Monday, March 30th, 2020
  • Work will continue with respect to activities in which social distancing and best health practices can be observed, such as developing the new PUREVAP™Â Silicon Metal Nano Reactor, (PUREVAP™Â SiNR).

MONTREAL, March 30, 2020  — HPQ Silicon Resources Inc. (“HPQ” or the “Company”) TSX-V: HPQ; FWB: UGE; Other OTC : URAGF; would like to inform shareholders that in response to the ongoing Coronavirus (COVID-19) outbreak, HPQ and its partners PyroGenesis in Montreal, and Apollon in France, and suppliers are respecting the health and safety of employees by encouraging employees to isolate, and work from home as much as possible.  Given the severity of the outbreak and continuing uncertainty regarding the duration and business impact of the virus, the start of the Gen3 Pilot Plant commissioning and testing program is being postponed until further notice.  However, work will continue with respect to activities in which social distancing and best health practices can be observed, such as developing the new PUREVAP™Â Silicon Metal Nano Reactor, (PUREVAP™Â SiNR).

BATTERY INDUSTRY INTEREST IN HPQ CONTINUES TO REMAIN STRONG

Despite the current circumstances, battery industry participants continue to inquire and demonstrate strong interest in our future upstream production capabilities.  Specifically, we are seeing meaningful interest in using our PUREVAP™ RRQ Silicon Metal (Si) as feed stock to manufacture:

So much so that, as soon as possible once the COVID-19 business interruption ends, our primary focus will be on manufacturing sufficient quantities of material to deliver samples to battery manufacturers and research centres. Only once these goals have been attained will we re-deploy assets to the Gen3 Pilot Plant commissioning and testing program. This is the level of importance of this initiative.

“The COVID-19 outbreak, possible recession and low oil prices don’t change the long-term cyclical movement of the Renewable Energy Revolution (“RER”).  HPQ is building a portfolio of unique High Value Silicon Metal products needed for the RER and the short-term business interruption we are experiencing has no bearing on the long-term potential of what we are doing. The continued interest in HPQ from the battery industry despite COVID-19 interruptions provides unequivocal evidence of this,” said Bernard Tourillon, President and CEO HPQ Silicon.  â€œInterest in the potential for Silicon Metal’s potential to contribute to energy storage demand is undeniable and generating massive investments, as well as, serious industry interest. This was true before the COVID-19 outbreak and will be true after.”

About Silicon Metal

Silicon Metal (Si) is one of today’s strategic material needed to fulfil the renewable energy revolution presently under way. Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a costly and energy intensive process.  

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is developing, with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, the innovative PUREVAP™ â€œQuartz Reduction Reactors” (QRR), a process (patent pending), which will permit the One Step transformation of Quartz (SiO2) into High Purity Silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential.

HPQ, working with PyroGenesis, is also developing the PUREVAP™ Silicon Metal Nano Reactor (SiNR). This is a proprietary process that uses different purities of Silicon Metal (SI as feedstock), melts them into liquid Si that can then be synthesized into the Spherical Silicon Metal Nano Powders and Nanowires necessary for the next generation of Lithium-ion batteries.  During 2020, the plan is to validate our game changing manufacturing approach by upgrading our existing Gen2 PUREVAP™ QRR reactor into a PUREVAP™ SiNR to produce spherical Silicon Metal (Si) nano-powders and nanowires samples for industry participants and research institutions’.

Concurrently, HPQ is also working with industry leader Apollon Solar to develop a manufacturing capability that uses the High Purity Silicon (Si) made with the PUREVAP™ to make Porous silicon wafers needed for solid-state Li-ion batteries.  We expect that the first Silicon wafer should be ready to be shipped for testing to a battery manufacturer (under NDA) in 2020.

The focus of HPQ focus is to become the lowest cost producer of Silicon Metal (Si), High Purity Silicon Metal (Si), Spherical Si nano-powders and silicon-based composites for next-generation lithium-ion batteries, Porous Silicon Wafers for Solid states batteries and Porous Silicon Powders for Li-ion batteries.

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders. 

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact
Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

VIDEO: Hollister $HOLL.ca Closes $20,000,000 Acquisition, Adds $16.4M Revenue & $2.5M EBITDA $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 9:21 AM on Monday, March 30th, 2020

At a time when established Cannabis stocks are struggling due to an inability to actually deliver real businesses, Hollister Biosciences (HOLL:CSE) has been quietly building a real business, products, revenue and customers in 220 of California’s 600 dispensaries …. and growing, including California’s #1 hash infused pre-roll “Hashbone”.  

If that was all Hollister had going, they’d be in great shape with a super bright future and better than most Cannabis companies (small and large) who can’t even get product out the door.  

BUT THERE’S MORE – THE $20,000,000 ACQUISITION THAT COMES WITH $CDN 16.4M REVENUE & $CDN 2.48M EBITDA  

Hollister has closed their purchase of Venom Extracts, one of Arizona’s largest producers of Award-Winning Medical Cannabis Distillate. Just how good is Venom? In 2019, Venom generated $CDN 16.4M in revenue and $CDN 2.48M EBITDA in 2019 … and all of that was just from the state of Arizona.   

In this amazing interview, Venom Founder Jake Cohen discusses Venom’s aggressive plans to expand its brand and success into other states, including California as it benefits from Hollister’s distribution into 220 dispensaries.  Right now, some of you may be thinking, “yeah but everybody thinks they are going to expand” …. but Jake’s words, as well as those of Alex Somjen (President) and Carl Saling (CEO) are backed up by action.    

Specifically, a significant chunk of Venom’s acquisition shares kicks in if/when revenues hit $CDN 30,000 and $CDN 40,000 …. by December 31, 2021.  In my experience, companies joining forces don’t include such terms if there isn’t a reasonable expectation for hitting those numbers.  It doesn’t guarantee it but you can bet they have good reason to believe Venom sales will get to one or both of those numbers in just 21 months from now.  

If you’re looking for Cannabis companies that are going to survive and thrive over this next decade, then grab your favourite beverage and watch this great interview with Carl Saling, Alex Somjen and Jacob Cohen.

DATAMETREX #DM.ca WORKING WITH US GOVERNMENT AGENCIES ON #COVID19 AND #CORONAVIRUS

Posted by AGORACOM-JC at 7:23 AM on Monday, March 30th, 2020
  • Company is currently working with various agencies within the United States Government on the mass amount of social media surrounding #coronavirus and #covid19
  • “We are thrilled to be working with the US Government on this very important issue. We recently completed work for Democracy Labs on #disinformation in social media regarding #covid19 and #coronavirus and secured a relationship with Carnegie Mellon University IDeaS…”

TORONTO, March 30, 2020  — Datametrex AI Limited (the “Company” or “Datametrex”) is pleased to share that the Company is currently working with various agencies within the United States Government on the mass amount of social media surrounding #coronavirus and #covid19. We will provide greater detail on the work we are doing once it is completed and our clients approve it for public dissemination. 

“We are thrilled to be working with the US Government on this very important issue. We recently completed work for Democracy Labs on #disinformation in social media regarding #covid19 and #coronavirus and secured a relationship with Carnegie Mellon University IDeaS. Both announcements assisted in getting Nexalogy in front of the Government Agencies for this current opportunity in the United States. The solid foundation we have built over the past years with our Canadian Government clients like  DRDC, the Canadian Military and NATO have positioned Datametrex to be able to provide military grade solutions for todays social media challenges”, says Marshall Gunter CEO of Datametrex AI.

About Datametrex AI Limited

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at: www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Hollister Biosciences $HOLL.ca Closes Transformational Acquisition of Rapidly Growing Venom Extracts Adding Over $16.4 Million In 2019 Revenue and $2.5 Million in EBITDA $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 7:18 AM on Monday, March 30th, 2020

This highly accretive acquisition strengthens Hollister’s brand portfolio and broadens its distribution footprint across multiple states positioning Hollister to transform into an industry leader in 2020 and beyond

  • Venom Extracts reports having generated over CDN$16.4 million in revenue and over CDN$2.5 million in EBITDA from its product line of cannabis concentrates and cartridges. 

VANCOUVER, March 30, 2020  – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister“), a diversified cannabis branding company with products in 220 dispensaries throughout California, is pleased to announce that further to the signing of the definitive agreement, as amended (the “SEA“), the Company has now closed its transformational acquisition of Venom Extracts (“Venom Extracts“), a leading Arizona cannabis extract brand and one of the state’s largest producers of award-winning medical cannabis distillate and related products (the “Transaction“).

HIGHLY ACCRETIVE $20,000,000 ACQUISITION, ADDING OVER CDN$16.4 MILLION OF 2019 REVENUE

For the year ended December 31, 2019, management of Venom Extracts reports having generated over CDN$16.4 million in revenue and over CDN$2.5 million in EBITDA from its product line of cannabis concentrates and cartridges.  Venom Extract’s management also reports a strong start to 2020 and is anticipating record Q1 revenue.

The all-stock purchase price of approximately CDN$20,000,000 represents a transaction multiple of 1.2x 2019 revenue, with approximately 70% of the consideration paid upfront and the approximately 30% balance to be paid upon milestone achievements related to revenue targets for Venom Extracts, or in any event, on December 31, 2021.  After conducting normal course due diligence, the Transaction closed effective March 24, 2020 (the “Closing Date“).

KEY TERMS OF THE TRANSACTION:

Pursuant to the terms of the SEA, the Company has acquired Venom Extracts for consideration of CDN$20,000,145.20 which is to be satisfied by the issuance of 70,390,672 Hollister common shares (the “Payment Shares“) on the Closing Date pro rata to the shareholders of Venom Extracts and an additional 29,610,054 common shares (the “Earn-Out Shares“) to certain former shareholders of Venom Extracts on the earlier of (i) Venom Extracts reaching certain revenue milestones (detailed below), or (ii) December 31, 2021.

  • The Payment Shares and the Earn-Out Shares will be issued at a deemed value of CDN$0.20 per share;
  • The Payment Shares are subject to certain voluntary hold periods with 90% of the Payment Shares being subject to hold periods as follows: 15% until May 25, 2020; and an additional 15% every six months until November 25, 2022;
  • The Earn-Out Shares will be issued on the earlier of (i) December 31, 2021, or (ii) when and if the following milestones have been met:
    • 19,740,036 Earn-Out Shares will be issued when revenue of Venom Extracts reaches CDN$30,000,000 (calculated in accordance with IFRS from January 1, 2020); and
    • An additional 9,870,018 Earn-Out Shares will be issued when revenue of Venom Extracts reaches CDN$40,000,000 (calculated in accordance with IFRS from January 1, 2020).

“We are extremely pleased to complete this transformational and highly accretive acquisition”, shared Carl Saling, Founder and CEO of Hollister Biosciences Inc. “Our acquisition of Venom Extracts bolts on substantial revenue and EBITDA to Hollister, while providing Venom Extracts the ability to expand its offering of premium branded product into the California marketplace. Likewise, our acquisition also allows Hollister to introduce its products into the Arizona and Nevada marketplaces through Venom Extracts’ existing distribution channels.”

“This is an exciting acquisition and we are very pleased to announce closing”, shared Jacob Cohen, Founder of Venom Extracts.  “This transaction represents the next step in ensuring the future growth of both Hollister and Venom Extracts.  We are looking forward to increasing our geographic presence by expanding into the California marketplace through Hollister’s existing platform, and exploring expansion of our existing product portfolio collectively.”

In association with the acquisition, Hollister will not be assuming any long-term debt, a new control position will be created and there is no change in management, or the board of directors of Hollister being contemplated at this time.

In connection with the Transaction, the Company issued 6,000,000 common shares (the “Finder Shares“) to an arm’s length third party finder at a deemed price of $0.20 per Finder Share.  The Finder Shares are subject to a statutory hold period of four months and a day from the Closing Date which expires July 25, 2020.

This press release is available on the Company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

None of the securities to be issued pursuant to the Transaction have been or will be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities laws, and any securities issued pursuant to the Transaction are anticipated to be issued in reliance upon available exemptions from such registration requirements pursuant to Rule 506(b) of Regulation D and/or Section 4(a)(2) of the U.S. Securities Act and applicable exemptions under state securities laws. In addition, the securities issued under an exemption from the registration requirements of the U.S. Securities Act will be “restricted securities” as defined under Rule 144(a)(3) of the U.S. Securities Act and will contain the appropriate restrictive legend as required under the U.S. Securities Act.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a diversified cannabis company with multiple, high-quality products now carried in 220 of Indus Holdings (CSE: INDS), Hollister’s exclusive distribution partner’s 600 dispensaries. This level of penetration is expected to grow as the Company accelerates its seed to shelf, high margin business and product development model.

Capitalizing on this success, Hollister’s vision is to become the sought-after premium brand portfolio of innovative, high quality cannabis across multiple states and hemp products nationwide.

Our wholly owned California subsidiary, Hollister Cannabis Co, is the 1st state and locally licensed Cannabis Company in the City of Hollister, California, the birthplace of the “American Biker” from which we embrace the outlaw roots of Hollister to drive our Company fearlessly down the road of success.

Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll ranked as California’s #1 hash infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures.

Website:  www.hollistercannabisco.com 

About Venom Extracts

Venom Extracts is one of Arizona’s premier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products.  With an experienced management team and unparalleled reputation for quality, Venom Extracts prides itself as a differentiated extraction company by producing legal Marijuana products at a price point that allows retailers to generate higher profits.  Focused on proprietary efficiencies, the Company is able to produce more product per square foot than its competition, maintaining lower costs and risks than a typical extraction company. The company’s expansion strategy is centered on entering new markets/states that are approved for medical cannabis use and/or approved or have a reasonable expectation to be approved for recreational use in the near future.  

Website:  www.venomextracts.com

The CSE does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/hollister-biosciences-closes-transformational-acquisition-of-rapidly-growing-venom-extracts-adding-over-16-4-million-in-2019-revenue-and-2-5-million-in-ebitda-301031366.html

CLIENT FEATURE: New Age Metals $NAM.ca River Valley #PGM Project Hosts 2.9Moz #Palladium Equivalent (M&I); #Sprott Owns 18.56% – $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 5:48 PM on Friday, March 27th, 2020
  • Palladium Is The Hottest Metal On The Planet
  • River Valley Hosts 2.9Moz Palladium Equivalent (Measured & Indicated)
  • Advancing to Pre-Feasibility Study
  • The Largest Undeveloped PGM Project In North America!
  • Eric Sprott Owns 18.56% Of THIS Palladium Company

River Valley PGM Project near Sudbury, ON

  • Palladium is the main payable metal accounting for 65% of revenue stream based on 2019 PEA.
  • 1:0.4 (Pd:Pt).
  • Excellent infrastructure and within 100 kilometers of the Sudbury Metallurgical Complex.
  • NI 43-101 Mineral Resource Estimation (Q1 2019)
  • PEA done Q3 2019.
  • 2020 plan to follow up on PEA recommendations.

Preliminary Economic Assessment demonstrates positive economics for a large-scale open pit mining operation.

PEA Highlights (CDN$):

  • Life of mine (LOM) of 14 years, with 6 million tonnes annually of potential process plant feed at an average grade of 0.88 g/t Palladium Equivalent (PdEq) and process recovery rate of 80%, resulting in an annual average payable PdEq production of 119,000 ounces.
  • Pre-Production capital requirements: $495 M.
  • Undiscounted cash flow before income and mining taxes of $586M.
  • Undiscounted cash flow after income and mining taxes of $384M.
  • Average unit operating cost of $19.50/tonne over the life-of-mine.
  • Potential for up to 325 jobs at the peak of production.
  • Using March 11, 2020 spot Palladium price (US$2,275/oz) River Valley Project After-tax IRR is 30% and After-tax NPV (5%) is $C858M.

New Age Metals Inc. is an advertising client of AGORA Internet Relations Corp.

Mota Ventures $MOTA.ca Successful Immune Line Launch Signs Up Over 5,500 New Customers in 12 Days $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 5:06 PM on Friday, March 27th, 2020
  • Since March 14, 2020, Mota has acquired over 5,500 new customers
  • The product has yielded an average initial order value of $189.00 USD.

Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTCPINK:PEMTF) (the “Company” or “Mota“) is pleased to announce that since the launch of its Immune Support product line on March 14, 2020, the Company has acquired over 5,500 new customers seeking natural solutions to help support their family’s immune systems. The popularity of the primary product has yielded an average initial order value for immune support customers of $189.00 USD. Earlier this week the Company introduced an Immune CBD oil and Elderberry Gummies. The new Immune CBD product contains CBD, B3, B12, vitamin C and zinc and is made from 100% pure essential oils containing cinnamon leaf, lemon, clove bud, lime, eucalyptus, globulus, rosemary, peppermint, spearmint and oregano.

The Company has acquired over 50,000 new customer inquiries for Immune Support/CBD products since March 14, 2020. The Immune Support line is gaining interest from customers that historically were hesitant to purchase CBD, but are now interested in the Immune products and the potential anti-inflammatory benefits of CBD. In addition, traditional brick-and-mortar stores have been affected due to social distancing requirements, driving consumers to purchase online from the safety of their homes.

“The Immune Support product launch has been the most successful product launch in the history of our First Class brand. E-Commerce is a fast-moving sector, especially during these very unique times we are facing today. Our ability as a company to quickly develop and launch new products to meet market demand is a testament to our expertise. I am very excited by the reception we have received to date for our Immune Line of products. I project demand for the line will continue through Q2 and be a significant driver to our growth for 2020,” stated Ryan Hoggan, CEO of the Company.

Additionally, the Company has entered into a 12 month programmatic digital advertising campaign with Native Ads, Inc. for a total cost of C$80,000; consisting of C$72,000 for digital advertising, paid distribution, and media buying over the campaign period and, C$8,000 for content creation, consulting, managed services and management fees over the course of the campaign period. Native Ads is a full-service advertising agency, that owns and operates a proprietary ad exchange with over 80 integrated SSPs (supply side platforms) resulting in access to 3-7 billion daily North American ad impressions. Neither Native Ads nor any of its directors and officers own any securities of the Company.

About Mota Ventures Corp.

Mota is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota.

ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact the President of the Company, Joel Shacker, at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

The thematic case for #Nickel – SPONSOR Tartisan #Nickel $TN.ca – $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 3:55 PM on Friday, March 27th, 2020

SPONSOR: Tartisan Nickel (TN:CSE)  Kenbridge Property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper. Tartisan also has interests in Peru, including a 20 percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property. Click her for more information

Tc logo in black

The thematic case for nickel

  • Nickel has exciting long-term prospects as its use in electric vehicle batteries is expected to drive its demand growth in the future
  • This structural trend has, however, not immunised it against the recent headwinds facing industrial metals

By Mobeen Tahir, Associate Director, Research, WisdomTree.

Nickel has exciting long-term prospects as its use in electric vehicle batteries is expected to drive its demand growth in the future. This structural trend has, however, not immunised it against the recent headwinds facing industrial metals. Industrial metals are cyclical commodities and their performance is fuelled by global economic growth. The sector has therefore been under pressure from trade wars and, more recently, coronavirus. In this blog, we want to shift the focus back to nickel’s strategic case. We remain cognizant that the current storm is not over yet but expect a smoother sail once the existing headwinds subside.

Analysing nickel’s recent history

Nickel has strongly outperformed the industrial metals basket (composed of copper, zinc, aluminium and nickel) in the last 3 years (Figure 1). The sector has faced challenges since the advent of trade wars in 2018 both directly due to tariffs and indirectly via a resulting slowdown in global economic activity. Nickel too has had its share of price volatility during this time. The metal rallied sharply in July 2019 on the expectation that Indonesia, which produces a quarter of global nickel supply, will bring forward its nickel ore export ban by 2 years to January 2020. Indonesia announced this decision soon thereafter. Concerns of supply shortages drove the price in a market which was already in a deficit. Nickel’s fortunes reversed in the last quarter of 2019 as stainless-steel demand, which currently accounts for nearly two-thirds of the metal’s use, dwindled. The dynamics of the nickel market are however changing which is why we have an optimistic view of the future.

Source: WisdomTree, Bloomberg. Monthly data from 01/01/2017 to 03/01/2020. Industrial metals basket refers to the Bloomberg Industrial Metals Subindex.

Battery solutions to take a larger share of nickel

According to metal experts Wood Makenzie, battery solutions are expected to account for more than 30% of the total demand for nickel by 2040, up from around 4% today (Figure 2). This is because electric vehicles are forecasted to be around 50% of all passenger car sales by 2040, up from around 8% today. Batteries need to become more efficient to enable this growth and nickel is expected to play a pivotal role. According to the Nickel Institute, nickel-containing Lithium-ion batteries are powering the electric vehicle revolution as nickel in batteries helps deliver higher energy density and greater storage capacity at a lower cost. This will allow electric cars to have both a longer range, i.e. the ability to drive longer distances without requiring a recharge, and lower cost promoting wider adoption.

Now, the impact on price from demand growth can, in theory, be offset by an equal increase in supply. We, however, believe that supply growth will be much slower as, according to Wood Mackenzie, the average time for a new nickel mining project to start producing the metal is around 9 years. Miners will seek higher prices to be incentivised to undertake such projects.

Source: WisdomTree, Wood Mackenzie. Forecasts (F) from 2019.

It is uncertain how quickly the current headwinds facing industrial metals will dissipate. Having said that, the market dynamics of nickel are changing and the long-term outlook appears promising for the metal supported by a thematic shift towards electric vehicles which is being powered by nickel-containing batteries. With the nickel market already in a supply deficit, we expect growing demand to support its price in the long-term.

Source: https://www.etfstrategy.com/wisdomtree-the-thematic-case-for-nickel-etf-49595/

#Covid19 fake news hacks its way onto government blockchain website – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 12:45 PM on Friday, March 27th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company announced three $1M contacts in Q3-2019. Click here for more info.

Covid-19 fake news hacks its way onto government blockchain website

By: Mariana López

  • On March 14, the government in Argentina disclosed that its system had effectively been hacked.
  • Perpetrator(s) uploaded false information regarding guidelines for public officials on handling the coronavirus (Covid-19) onto the country’s official bulletin website, which just so happens to use blockchain technology. 

As a result, officials took the site temporarily offline.

Correspondingly, another issuance will be necessary to disclaim the false statements posted on its 34,239 editions.

Have the blockchain gods forsaken the government of Buenos Aires? Not exactly. Blockchain isn’t bullet-proof.

Hacked! Why Argentina’s case is a big deal

Perhaps you’re wondering, “what’s the big deal? It’s just a bulletin.”

No, it’s not just a bulletin. 

Many countries have their own official bulletin or gazette wherein laws, notifications, or other big-deal, high-level government information is formally announced.

In Argentina, it’s known as the Boletín Oficial. Mexico’s is christiend the Diario Oficial de la Federación. In the US it’s called the Federal Register.

And the fact that something of such substantial importance in government communications was hacked is both alarming and interesting.

First off, blockchain-based systems are often hailed as more fool-proof to this type of manipulation. 

And that’s because each block within the chain is supposed to have its own unique cryptographic fingerprint and use what’s known as a “consensus protocol.” Through this protocol, the nodes on the network share and record transactional history. 

Thanks to these mechanisms, in theory, not just any outsider can show up and manipulate the data.

But with some creativity and determination, hackers can bust through blockchain’s apparently impenetrable defenses.

Secondly, everyone is well aware of how fake news can make its way onto social media. As a result, we’re consistently advised to only rely on official sources, like government websites, for more information on the pandemic. 

The hacking of a government outlet like Buenos Aires’ means that no source is 100 percent safe and fool-proof to being used as a platform to broadcast false statements.

That’s why we should make an effort to consult additional sources for more information. Especially for a topic as sensitive as healthcare.

And remember, if the government is hackable, so are you. So take the necessary precautions to protect your own data and systems.

Source: https://www.contxto.com/en/argentina/argentina-government-hacked-spread-fake-news/